Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

People In Brief

This article was originally published in The Gray Sheet

  • News

Executive Summary

Cook Group founder dies, son takes helm

You may also be interested in...



Financings In Brief

BG Medicine goes public

Beckman CEO Resigns As Company Faces Regulatory Challenges

Beckman Coulter announced the resignation of Scott Garrett as chairman, president and CEO Sept. 7 as the firm tries to recover from a recent FDA-triggered diagnostic test market withdrawal and ongoing regulatory scrutiny

'We Should Have Acted Sooner' On DTC Gene Tests, Shuren Tells Lawmakers

CDRH has been busy for the past two months in an effort to bring direct-to-consumer genetic test services into its regulatory fold, but Center Director Jeff Shuren acknowledged to a House subcommittee last week that the agency was slow to tackle the matter

Table

View full table

Tags:
Latest Headlines

ZimVie Wins Investigational Device Exemption For Disc Replacement Device, Plans To Begin Study

Theradaptive Receives $7.4M From DoD, Advances Human Trials With ‘Paint-Like’ Regenerative Therapeutic

Minute Insight: Virtual Incision Draws In Another $30m With Its Table-Top Surgical Robot

Generating And Assessing Evidence To Optimize MDR And IVDR Governance and Innovation

See All
UsernamePublicRestriction

Register

MT030070

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By